An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...
Since 2008, Labroots has used its virtual events to connect a global network of scientists regarding the latest advancements in their fields. These virtual | Drug Discovery And Development ...
Silicon nanotube arrays deliver functional mRNA into human pluripotent stem cells for the first time, achieving up to 64% transfection without compromising stem cell identity.
Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
A research rocket from the REXUS program launched into the stratosphere from the Esrange Space Center in Sweden, carrying the THRIVE module with components of the cell-based StellarHeal wound care ...
A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center report that ...
Add Yahoo as a preferred source to see more of our stories on Google. A Nature Immunology study suggests PARP inhibitors can reprogram CD8 T cells into longer-lasting “superior memory” cancer fighters ...
SmartCella Holding AB (“SmartCella”), a global biopharma company developing and manufacturing cutting-edge cell therapy approaches for difficult-to-treat diseases, and Catalent, Inc., the leader in ...
WASHINGTON — Tech titan Elon Musk celebrated the year-end success of his efforts to slash the federal workforce, as data show a nearly 9% reduction in the federal workforce that once employed more ...
Besides convenience, one of the main benefits of self-driving cars is supposed to be safety. Yet in a bizarre move, Waymo — whose self-driving cabs had been enjoying extraordinary safety metrics — has ...
This article discusses research by Dr. Lee J. Martin and his team on HIE, a leading cause of neonatal mortality. They use human induced pluripotent stem cells (iPSCs) and neural stem cells (NSCs) and ...
The International Society for Stem Cell Research (ISSCR) today announced that registration and abstract submission are open for the ISSCR International Symposium: 20 Years of iPSC Discovery: A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results